Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccinationViggo Van Tendeloo, Zwi Berneman, Katrien Pieters et al.|Proceedings of the National Academy of Sciences|2010Cited by 376
WT1-Targeted Dendritic Cell Vaccination as A Post-Remission Treatment to Prevent Full Relapse In Acute Myeloid LeukemiaZwi Berneman, Viggo Van Tendeloo, Ann an de Velde et al.|Blood|2010Cited by 6
Engineering with EP2/EP4 knockout and IL-15 transpresentation renders stem cell-derived NK cells self-persistent and resistant to PGE2 inhibitionMarcos Vidal-Manrique, Harry Dolstra, Laura Hooijmaijers et al.|Frontiers in Immunology|2026Cited by 0
Correction: Engineering with EP2/EP4 knockout and IL-15 transpresentation renders stem cell-derived NK cells self-persistent and resistant to PGE2 inhibitionMarcos Vidal-Manrique, Harry Dolstra, Laura Hooijmaijers et al.|Frontiers in Immunology|2026Cited by 0